{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:43:02Z","timestamp":1776861782831,"version":"3.51.2"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Cabrini Institute Medical Staff Research Scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00520-020-05606-7","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T01:21:42Z","timestamp":1593998502000},"page":"1327-1335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of methadone in cancer-induced bone pain: a retrospective cohort study"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5610-4023","authenticated-orcid":false,"given":"Merlina","family":"Sulistio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Wojnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seraphina","family":"Key","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Al-Rubaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"issue":"36","key":"5606_CR1","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1200\/JCO.2014.56.0383","volume":"32","author":"MT Greco","year":"2014","unstructured":"Greco MT, Roberto A, Corli O, Deandrea S, Bandieri E, Cavuto S, Apolone G (2014) Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol 32(36):4149\u20134154. https:\/\/doi.org\/10.1200\/JCO.2014.56.0383","journal-title":"J Clin Oncol"},{"issue":"6","key":"5606_CR2","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"MH van den Beuken-van Everdingen","year":"2016","unstructured":"van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ (2016) Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manag 51(6):1070\u20131090 e1079. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.12.340","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"5606_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","volume":"27","author":"RE Coleman","year":"2001","unstructured":"Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27(3):165\u2013176. https:\/\/doi.org\/10.1053\/ctrv.2000.0210","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"5606_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0304-3959(95)00076-3","volume":"64","author":"S Grond","year":"1996","unstructured":"Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA (1996) Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 64(1):107\u2013114. https:\/\/doi.org\/10.1016\/0304-3959(95)00076-3","journal-title":"Pain"},{"issue":"1\u20132","key":"5606_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0304-3959(96)03267-8","volume":"69","author":"S Mercadante","year":"1997","unstructured":"Mercadante S (1997) Malignant bone pain: pathophysiology and treatment. Pain 69(1\u20132):1\u201318. https:\/\/doi.org\/10.1016\/s0304-3959(96)03267-8","journal-title":"Pain"},{"issue":"10","key":"5606_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/iju.13170","volume":"23","author":"S Tsuzuki","year":"2016","unstructured":"Tsuzuki S, Park SH, Eber MR, Peters CM, Shiozawa Y (2016) Skeletal complications in cancer patients with bone metastases. Int J Urol 23(10):825\u2013832. https:\/\/doi.org\/10.1111\/iju.13170","journal-title":"Int J Urol"},{"issue":"1","key":"5606_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jpainsymman.2013.02.015","volume":"47","author":"S Deandrea","year":"2014","unstructured":"Deandrea S, Corli O, Consonni D, Villani W, Greco MT, Apolone G (2014) Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manag 47(1):57\u201376. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.02.015","journal-title":"J Pain Symptom Manag"},{"issue":"Suppl 1","key":"5606_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4137\/CGM.S21215","volume":"8","author":"LM Slosky","year":"2015","unstructured":"Slosky LM, Largent-Milnes TM, Vanderah TW (2015) Use of animal models in understanding cancer-induced bone pain. Cancer Growth Metastasis 8(Suppl 1):47\u201362. https:\/\/doi.org\/10.4137\/CGM.S21215","journal-title":"Cancer Growth Metastasis"},{"issue":"1","key":"5606_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.expneurol.2004.11.028","volume":"193","author":"CM Peters","year":"2005","unstructured":"Peters CM, Ghilardi JR, Keyser CP, Kubota K, Lindsay TH, Luger NM, Mach DB, Schwei MJ, Sevcik MA, Mantyh PW (2005) Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Exp Neurol 193(1):85\u2013100. https:\/\/doi.org\/10.1016\/j.expneurol.2004.11.028","journal-title":"Exp Neurol"},{"issue":"3","key":"5606_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1200\/JCO.1991.9.3.509","volume":"9","author":"OS Nielsen","year":"1991","unstructured":"Nielsen OS, Munro AJ, Tannock IF (1991) Bone metastases: pathophysiology and management policy. J Clin Oncol 9(3):509\u2013524. https:\/\/doi.org\/10.1200\/JCO.1991.9.3.509","journal-title":"J Clin Oncol"},{"issue":"5","key":"5606_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/cancers10050141","volume":"10","author":"SH Park","year":"2018","unstructured":"Park SH, Eber MR, Widner DB, Shiozawa Y (2018) Role of the bone microenvironment in the development of painful complications of skeletal metastases. Cancers (Basel) 10(5):141. https:\/\/doi.org\/10.3390\/cancers10050141","journal-title":"Cancers (Basel)"},{"key":"5606_CR12","doi-asserted-by":"publisher","first-page":"h315","DOI":"10.1136\/bmj.h315","volume":"350","author":"CM Kane","year":"2015","unstructured":"Kane CM, Hoskin P, Bennett MI (2015) Cancer induced bone pain. BMJ 350:h315. https:\/\/doi.org\/10.1136\/bmj.h315","journal-title":"BMJ"},{"key":"5606_CR13","doi-asserted-by":"publisher","unstructured":"Zajaczkowska R, Kocot-Kepska M, Leppert W, Wordliczek J (2019) Bone pain in cancer patients: mechanisms and current treatment. Int J Mol Sci 20(23). https:\/\/doi.org\/10.3390\/ijms20236047","DOI":"10.3390\/ijms20236047"},{"issue":"6","key":"5606_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2015.63.8221","volume":"34","author":"M Fallon","year":"2016","unstructured":"Fallon M, Hoskin PJ, Colvin LA, Fleetwood-Walker SM, Adamson D, Byrne A, Murray GD, Laird BJ (2016) Randomized double-blind trial of pregabalin versus placebo in conjunction with palliative radiotherapy for cancer-induced bone pain. J Clin Oncol 34(6):550\u2013556. https:\/\/doi.org\/10.1200\/JCO.2015.63.8221","journal-title":"J Clin Oncol"},{"issue":"3","key":"5606_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/15360288.2014.938883","volume":"28","author":"P Good","year":"2014","unstructured":"Good P, Afsharimani B, Movva R, Haywood A, Khan S, Hardy J (2014) Therapeutic challenges in cancer pain management: a systematic review of methadone. J Pain Palliat Care Pharmacother 28(3):197\u2013205. https:\/\/doi.org\/10.3109\/15360288.2014.938883","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"3","key":"5606_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/s0889-8588(02)00017-5","volume":"16","author":"C Ripamonti","year":"2002","unstructured":"Ripamonti C, Bianchi M (2002) The use of methadone for cancer pain. Hematol Oncol Clin North Am 16(3):543\u2013555. https:\/\/doi.org\/10.1016\/s0889-8588(02)00017-5","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"5606_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s005200000180","volume":"9","author":"MP Davis","year":"2001","unstructured":"Davis MP, Walsh D (2001) Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer 9(2):73\u201383. https:\/\/doi.org\/10.1007\/s005200000180","journal-title":"Support Care Cancer"},{"issue":"7","key":"5606_CR18","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1742-1241.2008.01990.x","volume":"63","author":"W Leppert","year":"2009","unstructured":"Leppert W (2009) The role of methadone in cancer pain treatment--a review. Int J Clin Pract 63(7):1095\u20131109. https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01990.x","journal-title":"Int J Clin Pract"},{"issue":"6","key":"5606_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.clon.2011.03.003","volume":"23","author":"T Middlemiss","year":"2011","unstructured":"Middlemiss T, Laird BJ, Fallon MT (2011) Mechanisms of cancer-induced bone pain. Clin Oncol R Coll Radiol (Great Britain) 23(6):387\u2013392. https:\/\/doi.org\/10.1016\/j.clon.2011.03.003","journal-title":"Clin Oncol R Coll Radiol (Great Britain)"},{"issue":"8","key":"5606_CR20","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1634\/theoncologist.2015-0503","volume":"21","author":"J Porta-Sales","year":"2016","unstructured":"Porta-Sales J, Garzon-Rodriguez C, Villavicencio-Chavez C, Llorens-Torrome S, Gonzalez-Barboteo J (2016) Efficacy and safety of methadone as a second-line opioid for cancer pain in an outpatient clinic: a prospective open-label study. Oncologist 21(8):981\u2013987. https:\/\/doi.org\/10.1634\/theoncologist.2015-0503","journal-title":"Oncologist"},{"issue":"2","key":"5606_CR21","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/cncr.24754","volume":"116","author":"HA Parsons","year":"2010","unstructured":"Parsons HA, de la Cruz M, El Osta B, Li Z, Calderon B, Palmer JL, Bruera E (2010) Methadone initiation and rotation in the outpatient setting for patients with cancer pain. Cancer 116(2):520\u2013528. https:\/\/doi.org\/10.1002\/cncr.24754","journal-title":"Cancer"},{"issue":"2","key":"5606_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jpainsymman.2015.02.029","volume":"50","author":"S McLean","year":"2015","unstructured":"McLean S, Twomey F (2015) Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence. J Pain Symptom Manag 50(2):248\u2013259 e241. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.02.029","journal-title":"J Pain Symptom Manag"},{"issue":"Suppl 4","key":"5606_CR23","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CI, Committee EG (2018) Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol 29(Suppl 4):iv166\u2013iv191. https:\/\/doi.org\/10.1093\/annonc\/mdy152","journal-title":"Ann Oncol"},{"issue":"10","key":"5606_CR24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.5694\/j.1326-5377.2000.tb139323.x","volume":"173","author":"OT Ayonrinde","year":"2000","unstructured":"Ayonrinde OT, Bridge DT (2000) The rediscovery of methadone for cancer pain management. Med J Aust 173(10):536\u2013540","journal-title":"Med J Aust"},{"issue":"3","key":"5606_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jpainsymman.2018.12.001","volume":"57","author":"ML McPherson","year":"2019","unstructured":"McPherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J, Malotte K, Lockman DK, Wellman C, Salpeter S, Bemben NM, Ray JB, Lapointe BJ, Chou R (2019) Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manag 57(3):635\u2013645 e634. https:\/\/doi.org\/10.1016\/j.jpainsymman.2018.12.001","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"5606_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpain.2016.10.020","volume":"18","author":"JA Paice","year":"2017","unstructured":"Paice JA, Mulvey M, Bennett M, Dougherty PM, Farrar JT, Mantyh PW, Miaskowski C, Schmidt B, Smith TJ (2017) AAPT diagnostic criteria for chronic cancer pain conditions. J Pain Off J Am Pain Soc 18(3):233\u2013246. https:\/\/doi.org\/10.1016\/j.jpain.2016.10.020","journal-title":"J Pain Off J Am Pain Soc"},{"key":"5606_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1472-684X-4-7","volume":"4","author":"AP Abernethy","year":"2005","unstructured":"Abernethy AP, Shelby-James T, Fazekas BS, Woods D, Currow DC (2005) The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]. BMC Palliat Care 4:7. https:\/\/doi.org\/10.1186\/1472-684X-4-7","journal-title":"BMC Palliat Care"},{"issue":"3","key":"5606_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/s0304-3959(01)00465-1","volume":"96","author":"N Moryl","year":"2002","unstructured":"Moryl N, Santiago-Palma J, Kornick C, Derby S, Fischberg D, Payne R, Manfredi PL (2002) Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain. Pain 96(3):325\u2013328. https:\/\/doi.org\/10.1016\/s0304-3959(01)00465-1","journal-title":"Pain"},{"issue":"8","key":"5606_CR29","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1089\/jpm.2007.0285","volume":"11","author":"PW Walker","year":"2008","unstructured":"Walker PW, Palla S, Pei BL, Kaur G, Zhang K, Hanohano J, Munsell M, Bruera E (2008) Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med 11(8):1103\u20131108. https:\/\/doi.org\/10.1089\/jpm.2007.0285","journal-title":"J Palliat Med"},{"issue":"3","key":"5606_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4103\/2229-3485.100662","volume":"3","author":"MP Barde","year":"2012","unstructured":"Barde MP, Barde PJ (2012) What to use to express the variability of data: standard deviation or standard error of mean? Perspect Clin Res 3(3):113\u2013116. https:\/\/doi.org\/10.4103\/2229-3485.100662","journal-title":"Perspect Clin Res"},{"issue":"7","key":"5606_CR31","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1089\/jpm.2018.0490","volume":"22","author":"S Okayama","year":"2019","unstructured":"Okayama S, Matsuda Y, Yoshikawa Y (2019) A comparative study of opioid switching to methadone for cancer pain control in successful and unsuccessful cases. J Palliat Med 22(7):844\u2013847. https:\/\/doi.org\/10.1089\/jpm.2018.0490","journal-title":"J Palliat Med"},{"issue":"3\u20134","key":"5606_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/15360288.2019.1666956","volume":"33","author":"SY Khoo","year":"2019","unstructured":"Khoo SY, Aziz FA, Nambbiar P (2019) Opioid rotation to methadone for refractory cancer pain: a case series. J Pain Palliat Care Pharmacother 33(3\u20134):125\u2013130. https:\/\/doi.org\/10.1080\/15360288.2019.1666956","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"5","key":"5606_CR33","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00520-015-2678-9","volume":"23","author":"B Afsharimani","year":"2015","unstructured":"Afsharimani B, Kindl K, Good P, Hardy J (2015) Pharmacological options for the management of refractory cancer pain-what is the evidence? Support Care Cancer 23(5):1473\u20131481. https:\/\/doi.org\/10.1007\/s00520-015-2678-9","journal-title":"Support Care Cancer"},{"issue":"11","key":"5606_CR34","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1089\/jpm.2013.0222","volume":"16","author":"W Rhondali","year":"2013","unstructured":"Rhondali W, Tremellat F, Ledoux M, Ciais JF, Bruera E, Filbet M (2013) Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study. J Palliat Med 16(11):1382\u20131387. https:\/\/doi.org\/10.1089\/jpm.2013.0222","journal-title":"J Palliat Med"},{"issue":"5","key":"5606_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1526-4637.2008.00461.x","volume":"9","author":"DJ Weschules","year":"2008","unstructured":"Weschules DJ, Bain KT (2008) A systematic review of opioid conversion ratios used with methadone for the treatment of pain. Pain Med 9(5):595\u2013612. https:\/\/doi.org\/10.1111\/j.1526-4637.2008.00461.x","journal-title":"Pain Med"},{"issue":"22","key":"5606_CR36","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.1200\/JCO.2005.13.128","volume":"23","author":"S Mercadante","year":"2005","unstructured":"Mercadante S, Ferrera P, Villari P, Casuccio A (2005) Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol 23(22):5229\u20135234. https:\/\/doi.org\/10.1200\/JCO.2005.13.128","journal-title":"J Clin Oncol"},{"issue":"5","key":"5606_CR37","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jpainsymman.2016.05.022","volume":"52","author":"P Poulain","year":"2016","unstructured":"Poulain P, Berleur MP, Lefki S, Lefebvre D, Chvetzoff G, Serra E, Tremellat F, Derniaux A, Filbet M, Group ES (2016) Efficacy and safety of two methadone titration methods for the treatment of cancer-related pain: the EQUIMETH2 Trial (Methadone for Cancer-Related Pain). J Pain Symptom Manag 52(5):626\u2013636 e621. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.05.022","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"5606_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1526-4637.2012.01334.x","volume":"13","author":"S Mercadante","year":"2012","unstructured":"Mercadante S (2012) Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. Pain Med 13(3):399\u2013404. https:\/\/doi.org\/10.1111\/j.1526-4637.2012.01334.x","journal-title":"Pain Med"},{"key":"5606_CR39","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3389\/fphar.2017.00733","volume":"8","author":"M Michalska","year":"2017","unstructured":"Michalska M, Katzenwadel A, Wolf P (2017) Methadone as a \u201ctumor theralgesic\u201d against cancer. Front Pharmacol 8:733. https:\/\/doi.org\/10.3389\/fphar.2017.00733","journal-title":"Front Pharmacol"},{"issue":"4","key":"5606_CR40","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1073\/pnas.89.4.1169","volume":"89","author":"R Maneckjee","year":"1992","unstructured":"Maneckjee R, Minna JD (1992) Nonconventional opioid binding sites mediate growth inhibitory effects of methadone on human lung cancer cells. Proc Natl Acad Sci U S A 89(4):1169\u20131173. https:\/\/doi.org\/10.1073\/pnas.89.4.1169","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"5606_CR41","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.leukres.2011.06.035","volume":"35","author":"A Singh","year":"2011","unstructured":"Singh A, Jayanthan A, Farran A, Elwi AN, Kim SW, Farran P, Narendran A (2011) Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition. Leuk Res 35(12):1649\u20131657. https:\/\/doi.org\/10.1016\/j.leukres.2011.06.035","journal-title":"Leuk Res"},{"issue":"5","key":"5606_CR42","doi-asserted-by":"publisher","first-page":"677","DOI":"10.18632\/oncotarget.952","volume":"4","author":"C Friesen","year":"2013","unstructured":"Friesen C, Roscher M, Hormann I, Fichtner I, Alt A, Hilger RA, Debatin KM, Miltner E (2013) Cell death sensitization of leukemia cells by opioid receptor activation. Oncotarget 4(5):677\u2013690. https:\/\/doi.org\/10.18632\/oncotarget.952","journal-title":"Oncotarget"},{"issue":"4","key":"5606_CR43","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.36076\/ppj.2011\/14\/E343","volume":"14","author":"R Vallejo","year":"2011","unstructured":"Vallejo R, Barkin RL, Wang VC (2011) Pharmacology of opioids in the treatment of chronic pain syndromes. Pain Phys 14(4):E343\u2013E360","journal-title":"Pain Phys"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05606-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05606-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05606-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T19:46:28Z","timestamp":1625514388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05606-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5606"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05606-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"4 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"NM is an advisory board member of Menarini Australia Ltd. The remaining authors have no conflict of interest disclosures to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local human research ethics committee (approval number 05-21-01-19).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Decoding of data is available and stored separately within the Cabrini Institute research database.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}